Background illustration for clinical trials search

Paid Clinical Trials Chicago

Discover 2,374 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

for
Crohn's Disease
Location: Chicago IL, Ypsilanti MI, Cincinnati OH, St Louis MO,
Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06045754

Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Chicago IL, Glenview IL, Naperville IL, Merrillville IN,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase3, Recruiting

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

for
B-cell Acute Lymphoblastic Leukemia
Location: Chicago IL, Madison WI, Nashville TN, Buffalo NY,
Sponsor: Cellectis S.A.

Sex: All

Age: 15 - 50

Code: NCT04150497

Phase1, Phase2, Recruiting

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

for
Advanced Hepatocellular Carcinoma,
Location: Chicago IL, Orland Park IL, New Lenox IL,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07166406

Phase3, Recruiting

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohn Disease
Location: Evanston IL, Detroit MI, Uniontown PA, Roanoke VA,
Sponsor: Abivax S.A.

Sex: All

Age: 18 - 70+

Code: NCT06456593

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Chicago IL, Skokie IL, Oak Brook IL, Indianapolis IN,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase1, Phase2, Recruiting

Role of Adiposomes in Endothelial Dysfunction

for
Obesity, Diabetes, Cardiovascular Diseases
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18 - 50

Code: NCT05199454

Recruiting

TNFerade Biologic to Treat Locally Advanced Prostate Cancer

for
Locally Advanced Prostate Cancer
Location: Chicago IL
Sponsor: GenVec

Sex: Male

Age: 0+

Code: NCT01048151

Phase1, Recruiting

Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. Veterans

for
Chronic Pain, Acute Pain, Fatigue, Depression
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT05094297

Recruiting

FIBERGRAFT Aeridyan Posterolateral Fusion Study

for
Degenerative Spine Disease
Location: Chicago IL, Lexington KY, Philadelphia PA, Boston MA,
Sponsor: DePuy Synthes Products, Inc.

Sex: All

Age: 18+

Code: NCT07059065

Recruiting

KITAMS: Kinesio Tape and Physical Function in Persons With Multiples Sclerosis

for
Multiple Sclerosis
Location: DeKalb IL
Sponsor: Northern Illinois University

Sex: All

Age: 18 - 50

Code: NCT03804047

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Chicago IL, Hinsdale IL, Grand Rapids MI, Decatur IL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase3, Recruiting

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

for
Small Cell Lung Cancer (SCLC)
Location: Chicago IL, Charlottesville VA, Boston MA
Sponsor: Alliance Foundation Trials, LLC.

Sex: All

Age: 18+

Code: NCT07149363

Phase2, Recruiting

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

for
Sickle Cell Disease Vaso-occlusive Crisis
Location: Chicago IL, Detroit MI, Cincinnati OH, St Louis MO,
Sponsor: CSL Behring

Sex: All

Age: 12+

Code: NCT06699849

Phase2, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Chicago IL, Maywood IL, Oak Lawn IL, Park Ridge IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase3, Recruiting

ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression

for
Depression
Location: Chicago IL, Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18 - 60

Code: NCT06408246

Phase2, Recruiting

Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

for
Abdominal Aortic Aneurysm,
Location: Skokie IL, Rochester MN, Cleveland OH, Lexington KY,
Sponsor: Medtronic Cardiovascular

Sex: All

Age: 20+

Code: NCT05378347

Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

for
Carcinoma, Non-Small-Cell Lung
Location: Chicago IL, Arlington Heights IL, Dyer IN,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06875310

Phase3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Chicago IL, Decatur IL, Bridgeton MO, Owensboro KY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase3, Recruiting

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

for
Sickle Cell Disease
Location: Chicago IL, St Louis MO, Columbus OH, Nashville TN
Sponsor: Ohio State University

Sex: All

Age: 18+

Code: NCT06919224

Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

The city of Chicago offers many advantages for individuals considering participation in clinical trials. With a diverse and vibrant population, researchers benefit from the variety of participants, improving the reliability and applicability of research findings across different demographics.

By opting to participate in a clinical trial in Chicago, individuals not only gain access to cutting-edge therapies and treatments but also contribute to vital medical research. This collaborative effort is supported by a robust clinical research infrastructure, ensuring participants receive high-quality care and attention while playing a crucial role in shaping the future of healthcare.

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago